Build a daily biotech analyst briefing
Rank coverage news, peer events, and follow-up work.
For repeatable research coverage
Turn biotech news flow into timelines, peer evidence, and research actions.
Build research context that compounds instead of restarting from a headline every morning.
Who this is for
Sell-side, buy-side, independent, and corporate analysts responsible for ongoing biotech company or therapeutic-area coverage.
The operating problem
Analysts must scan broadly, preserve primary sources, maintain historical context, and know when a non-coverage event changes a covered company.
Create a source-linked research layer connecting daily news with company histories, competitive landscapes, and upcoming catalysts.
Complete topic map
Every topic below opens a complete workflow guide with a concrete situation, decision process, monitoring checklist, common mistakes, and practical output.
01
Prioritize what changed and route it into ongoing research.
Rank coverage news, peer events, and follow-up work.
Use event types and coverage relevance to reduce reading load.
Look beyond the most visible clinical and FDA headlines.
02
Preserve the sequence behind the current investment story.
Connect guidance, outcomes, revisions, and future milestones.
Define expected data, comparators, and unresolved questions.
Compare earlier promises with actual delivery and later language.
03
Capture evidence beyond the formal ticker list.
Track programs, keywords, evidence, and upcoming catalysts.
Organize companies by scientific and clinical relationships.
Separate abstracts, new data, updates, and encore presentations.
Detailed workflow guides
01 · Daily research
Convert overnight company and industry updates into a prioritized coverage briefing before deeper research begins.
Read the workflow02 · Company research
Organize years of announcements into a sequence that shows how the company’s programs, promises, and risks evolved.
Read the workflow03 · Competitive research
Create a peer-monitoring system that captures indirect evidence across a therapeutic landscape.
Read the workflow04 · Daily coverage
Use event types and coverage relevance to reduce reading load.
Read the workflow05 · Daily coverage
Look beyond the most visible clinical and FDA headlines.
Read the workflow06 · Company and catalyst research
Define expected data, comparators, and unresolved questions.
Read the workflow07 · Company and catalyst research
Compare earlier promises with actual delivery and later language.
Read the workflow08 · Competitive and thematic coverage
Organize companies by scientific and clinical relationships.
Read the workflow09 · Competitive and thematic coverage
Separate abstracts, new data, updates, and encore presentations.
Read the workflowSupporting guides
Include material coverage-company events, relevant competitor evidence, timing changes, source links, a concise “what changed” statement, and assigned follow-up.
Timelines reveal guidance changes, execution history, evidence progression, and the relationship between past events and future catalysts.
Use program, target, modality, indication, and trial keywords in addition to ticker alerts, then normalize names and ownership in a landscape table.
Move from guide to workflow
BioPharmSignal brings biotech news, company context, PDUFA dates, watchlists, and alerts into one research surface.